CIS bio international
7 products tracked · names used in filings: CIS bio international
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Mon 03 Aug 2026🇪🇺 EU refusal
Deqtynet (copper (64Cu) oxodotreotide): EU marketing authorisation refused
Thu 21 May 2026🇪🇺 CHMP negative opinion
Deqtynet (copper (64Cu) oxodotreotide): CHMP negative opinion
CIS bio international; Orphan · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Deqtynet copper (64Cu) oxodotreotide | Refused | |
| 🇪🇺 | Scintimun besilesomab | Application withdrawn | |
| 🇪🇺 | Striascan ioflupane (123l) | Authorised | 2019-06-25 |
| 🇪🇺 | Ytracis yttrium [90Y] chloride | Withdrawn | 2003-03-24 |
| 🇪🇺 | NeoSpect depreotide | Withdrawn | 2000-11-29 |
| 🇪🇺 | Quadramet samarium [153Sm] lexidronam pentasodium | Authorised | 1998-02-04 |
| 🇪🇺 | Indimacis 125 igovomab | Withdrawn | 1996-10-04 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.